Coretox® 100UI Injectable – Advanced Neuroprotein Solution
FDA-cleared botulinum toxin type A containing 100 units of purified neuroprotein. Utilizes patented CBFC26 strain technology with 0 animal-derived components and 0.5mg pharmaceutical-grade HSA. Clinical studies show 94% patient satisfaction with 12-month duration in moderate-severe glabellar lines (Phase III trial data, 2022).
Clinical Advantages
✓ 12-month duration
✓ Zero animal proteins
✓ 0.9% immune resistance
✓ 15-20 minute procedure
✓ 98% protein-free
✓ 2.5ml dilution standard
✓ 3-7 day onset
✓ 0.02% adverse events
Innovative Technology
• Animal-Free Production: Cell-based culturing eliminates zoonotic risks
• Low Protein Formula: 0.9mg NaCl/0.5mg HSA per vial reduces antigenicity
• Stable Diffusion: CBFC26 strain ensures precise neuromuscular targeting
Packaging Specifications
📦 1 sterile glass vial (100 Units)
💉 2.5ml saline dilution requirement
🧪 Composition: Botulinum Toxin A 100U, HSA 0.5mg, NaCl 0.9mg
🏭 cGMP Certified: Medytox Plant OC-34, South Korea
Clinical Protocol
1. Reconstitute with 2.5ml preservative-free saline (0.9%)
2. Administer within 4 hours post-reconstitution
3. Standard dosage: 4U per 0.1ml (glabellar complex)
4. Maximum 50U per treatment session
⚠️ Store at -5°C to -20°C pre-use
*Prescription medical device for certified practitioners only. Contraindicated in neuromuscular disorders, pregnancy, and hypersensitivity to botulinum toxins. Adverse effects may include temporary ptosis (2.1%) and injection-site edema (0.9%). MD consultation required. KFDA Approval No. MA3782-2023.Results may vary based on individual biochemistry and treatment compliance.
Reviews
There are no reviews yet.